Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter

Use tags to find relevant records

3D printed implants

Ablation methods

Allogeneic mesenchymal stem cells

Ambulatory ECG monitoring

Aortic abdominal aneurysm

Aortic root replacement

Arthroplasty

Arthroscopy

Assisted ventilation

Atherectomy

Austria

Autologous chondrocyte implantation

Automated external defibrillator

AV fistula

AV graft

Balloon kyphoplasty

Bariatric surgery

Baroreflex activation therapy

Barrett’s oesophagus

Belgium

Benign prostatic hyperplasia

Biopsy

Bone Conductive Hearing Device

Breast reconstruction

Bronchial thermoplasty

Burns

Caesarean section

Cancer

Capsule endoscopy

Carbon ion therapy

Cardiac ablation

Cardiac computer tomography

Cardiac pacemaker

Cardiac resynchronization therapy

Cardiac Resynchronization Therapy Defibrillator (CRT-D)

Cardiovascular devices

Cardiovascular procedures

Carotid endarterectomy

Cataract

Cell therapy

Cholecystectomy

Chronic obstructive pulmonary disease

Chronic wounds

Clinical guidelines

Cochlear implants

Commissioning

Companion diagnostic tests

Computed tomography

Conditional reimbursement

Connected medical devices

Continuous glucose monitoring (CGM)

Coronary interventions

Coronary percutaneous revascularization procedures

Coronary procedures

Coronavirus

Coverage with evidence development (CED)

Drug-coated balloons

08

May 2017

The first peripheral drug-coated balloon is approved for add-on reimbursement in France

Ministerial decree to enlist Medtronic's IN.PACT Admiral for the LPPR title V for add-on reimbursement was published on 6th of May 2017 in the Official Journal of French Republic. This is not only the first peripheral DCB on the List, but one of the first invasive non-implantable devices to get add-on reimbursement in France.

01

May 2017

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.